Cetyltrimethylammonium Bromide Disrupts the Mesenchymal Characteristics of HA22T/VGH Cells<i>Via</i>Inactivation of c-Met/PI3K/Akt/mTOR Pathway

Chia-Herng Yue(Mackay Junior College of Medicine, Nursing and Management), CHIA-JEN LEE(Tungs' Taichung MetroHarbor Hospital)

Anticancer Research

July 29, 2020

10.21873/anticanres.14456

Cited by 5

Related Papers

Cetyltrimethylammonium Bromide Suppresses the Migration and Invasion of Hepatic Mahlavu Cells by Modulating Fibroblast Growth Factor Signaling

|Anticancer Research|2020|4

Cetyltrimethylammonium Bromide Attenuates the Mesenchymal Characteristics of Hypopharyngeal Squamous Cell Carcinoma Through Inhibiting the EGFR/PI3K/AKT Signaling Pathway

|Anticancer Research|2021|4

Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-β/Smad/miR-181b/TIMP3 Signaling Pathway

|Anticancer Research|2021|4